GlassScriptPhysician profile
Christopher John Ash
NPI 1295751550
$29,438.89
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,593 · 2020: $262 · 2021: $8,541 · 2022: $668 · 2023: $13K · 2024: $4,484 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Food and Beverage | $1,375.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,983.89 | 2019-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $280.11 | 2020-2023 | Oasis, Grafix Pl |
| Tela Bio, INC. | $193.98 | 2020-2024 | Ovitex 2s |
| Medtronic, INC. | $156.32 | 2021-2025 | Auto Suture |
| Kls-Martin L.P. | $134.00 | 2022 | |
| Acera Surgical, INC. | $125.37 | 2025 | Restrata Wound Matrix |
| Hologic Sales and Service, LLC | $120.77 | 2022 | |
| Kci USA, INC. | $87.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $82.74 | 2022 | |
| Davol INC. | $74.00 | 2019 | |
| Convatec INC. | $67.40 | 2019 | |
| Abbvie INC. | $41.81 | 2024 | |
| Covidien LP | $41.31 | 2019 | |
| Innocoll Pharmaceuticals Limited | $36.83 | 2022 | |
| Ethicon US, LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.